EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Decision-focused discovery toxicology: Why early, human-relevant risk assessment of new drugs gives a competitive advantage

Yvonne Will, Lindsey Talecki, Ruth Roberts

Current Opinion in Toxicology · 2026-12 · 48 · 100625

DOI: 10.1016/j.cotox.2026.100625 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Opinion in Toxicology, 2026-12. Verfasst von Yvonne Will und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Will, Y., Talecki, L., & Roberts, R. (2026). Decision-focused discovery toxicology: Why early, human-relevant risk assessment of new drugs gives a competitive advantage. Current Opinion in Toxicology, 48, 100625. https://doi.org/10.1016/j.cotox.2026.100625

Vancouver

Will Y, Talecki L, Roberts R. Decision-focused discovery toxicology: Why early, human-relevant risk assessment of new drugs gives a competitive advantage. Current Opinion in Toxicology. 2026;48:100625. doi:10.1016/j.cotox.2026.100625

BibTeX
@article{Will2026,
  author = {Will, Yvonne and Talecki, Lindsey and Roberts, Ruth},
  title = {Decision-focused discovery toxicology: Why early, human-relevant risk assessment of new drugs gives a competitive advantage},
  journal = {Current Opinion in Toxicology},
  year = {2026},
  volume = {48},
  pages = {100625},
  doi = {10.1016/j.cotox.2026.100625}
}
Kostenlos starten →